Horizon Therapeutics (HZNP) –
-
Warren Tells FTC She's Concerned About Amgen's (AMGN) Horizon (HZNP) Deal - Bloomberg
-
Form 15-12G Horizon Therapeutics
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: Watkins Thomas
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: Mahony Susan
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: Witz Pascale
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: GREY MICHAEL G
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: Daniel William F
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: Himawan Jeff
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: Shannon James Samuel
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: SANTINI GINO
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: McIlvenny Patrick
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: Pasternak Andy
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: Thompson Elizabeth H.Z.
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: Cox Aaron
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: Walbert Timothy P
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: DesJardin Michael A.
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: Clayton Sean M.
-
Form 4 Horizon Therapeutics For: Oct 06 Filed by: SHERMAN JEFFREY W
-
Form S-8 POS Horizon Therapeutics
-
Form S-8 POS Horizon Therapeutics
-
Form S-8 POS Horizon Therapeutics
-
Form S-8 POS Horizon Therapeutics
-
Form S-8 POS Horizon Therapeutics
-
Form S-8 POS Horizon Therapeutics
-
Form S-8 POS Horizon Therapeutics
-
Form S-8 POS Horizon Therapeutics
-
Form S-8 POS Horizon Therapeutics
-
Form S-8 POS Horizon Therapeutics
-
Form S-8 POS Horizon Therapeutics
-
Form 8-K Horizon Therapeutics For: Oct 06
-
Amgen completes $27.8 billion Horizon Therapeutics deal
-
Form 25-NSE Horizon Therapeutics Filed by: Nasdaq Stock Market LLC
-
Amgen (AMGN) Completes Acquisition of Horizon Therapeutics
-
Rule 17(e) Announcement - Horizon Therapeutics plc
-
Horizon Therapeutics (HZNP) says High Court of Ireland sanctioned scheme related to Amgen (AMGN) deal
-
Rule 17(d) Announcement – Horizon Therapeutics plc
-
Form 8-K Horizon Therapeutics For: Oct 05
-
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
-
Form 4 Horizon Therapeutics For: Oct 02 Filed by: SANTINI GINO
-
Form 4 Horizon Therapeutics For: Sep 29 Filed by: Watkins Thomas
-
Form 4 Horizon Therapeutics For: Sep 29 Filed by: Shannon James Samuel
-
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
-
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
-
Horizon Therapeutics (HZNP) Announces New UPLIZNA (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023
-
Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023
-
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
-
Horizon Therapeutics (HZNP) Reports New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA
-
New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes
-
Form 4 Horizon Therapeutics For: Sep 28 Filed by: GREY MICHAEL G
-
Form 4 Horizon Therapeutics For: Sep 26 Filed by: Himawan Jeff
Back to HZNP Stock Lookup